Pipeline Review on Batten Disease Therapeutic Industry, H1 2014

1
Batten Disease - Pipeline Review, H1 2014
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.

• Published January 2014
• Single User PDF US 2000
• Corporate User PDF US 6000

2
Batten Disease - Pipeline Review, H1 2014

• Batten Disease - Pipeline Review, H1 2014
  provides an overview of the indications
  therapeutic pipeline. This report provides
  information on the therapeutic development for
  Batten Disease, complete with latest updates, and
  special features on late-stage and discontinued
  projects. It also reviews key players involved in
  the therapeutic development for Batten Disease.
  Batten Disease - Pipeline Review, Half Year is
  built using data and information sourced from
  proprietary databases, Company/University
  websites, SEC filings, investor presentations and
  featured press releases from company/university
  sites and industry-specific third party sources.
• Complete Report of 44 pages is available _at_
  http//www.reportsnreports.com/reports/274906-batt
  en-disease-pipeline-review-h1-2014.html.
• Scope- A snapshot of the global therapeutic
  scenario for Batten Disease.- A review of the
  Batten Disease products under development by
  companies and universities/research institutes
  based on information derived from company and
  industry-specific sources.- Coverage of products
  based on various stages of development ranging
  from discovery till registration stages.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3
Batten Disease - Pipeline Review, H1 2014

• A feature on pipeline projects on the basis of
  monotherapy and combined therapeutics.- Coverage
  of the Batten Disease pipeline on the basis of
  route of administration and molecule type.- Key
  discontinued pipeline projects.- Latest news and
  deals relating to the products.
• Inquire for Discount _at_ http//www.reportsnreports.
  com/contacts/discount.aspx?name274906 .
• Reasons to buy- Identify and understand
  important and diverse types of therapeutics under
  development for Batten Disease.- Identify
  emerging players with potentially strong product
  portfolio and design effective counter-strategies
  to gain competitive advantage.- Plan mergers and
  acquisitions effectively by identifying players
  of the most promising pipeline.- Devise
  corrective measures for pipeline projects by
  understanding Batten Disease pipeline depth and
  focus of Indication therapeutics.- Develop and
  design in-licensing and out-licensing strategies
  by identifying prospective partners with the most
  attractive projects to enhance and expand
  business potential and scope.- Modify the
  therapeutic portfolio by identifying discontinued
  projects and understanding the factors that drove
  them from pipeline.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4
Batten Disease - Pipeline Review, H1 2014

• List of Tables
• Number of Products under Development for Batten
  Disease, H1 2014 7Number of Products under
  Development for Batten Disease - Comparative
  Analysis, H1 2014 8Number of Products under
  Development by Companies, H1 2014 9Number of
  Products under Investigation by
  Universities/Institutes, H1 2014 10Comparative
  Analysis by Clinical Stage Development, H1 2014
  11Comparative Analysis by Early Stage
  Development, H1 2014 12Products under
  Development by Companies, H1 2014 13Products
  under Investigation by Universities/Institutes,
  H1 2014 14Batten Disease - Pipeline by BioMarin
  Pharmaceutical Inc., H1 2014 15Batten Disease -
  Pipeline by ReGenX Biosciences, LLC, H1 2014
  16Batten Disease - Pipeline by Seneb
  BioSciences, Inc., H1 2014 17Assessment by
  Monotherapy Products, H1 2014 18Assessment by
  Combination Products, H1 2014 19

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
Batten Disease - Pipeline Review, H1 2014

• Number of Products by Stage and Target, H1 2014
  21Number of Products by Stage and Mechanism of
  Action, H1 2014 23Number of Products by Stage
  and Route of Administration, H1 2014 25Number of
  Products by Stage and Molecule Type, H1 2014
  27Number of Products by Stage and Therapeutic
  Class, H1 2014 29Batten Disease Therapeutics -
  Recent Pipeline Updates, H1 2014 35Batten
  Disease - Discontinued Products, H1 2014 36
• List of Figures
• List of FiguresNumber of Products under
  Development for Batten Disease, H1 2014 7Number
  of Products under Development for Batten Disease
  - Comparative Analysis, H1 2014 8Number of
  Products under Development by Companies, H1 2014
  9Number of Products under Investigation by
  Universities/Institutes, H1 2014 10Comparative
  Analysis by Clinical Stage Development, H1 2014
  11Comparative Analysis by Early Stage Products,
  H1 2014 12Assessment by Monotherapy Products, H1
  2014 18

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
6
Batten Disease - Pipeline Review, H1 2014

• List of Figures (Cont)
• Assessment by Combination Products, H1 2014
  19Number of Products by Top 10 Target, H1 2014
  20Number of Products by Stage and Top 10 Target,
  H1 2014 21Number of Products by Top 10 Mechanism
  of Action, H1 2014 22Number of Products by Stage
  and Top 10 Mechanism of Action, H1 2014 23Number
  of Products by Top 10 Route of Administration, H1
  2014 24Number of Products by Stage and Top 10
  Route of Administration, H1 2014 25Number of
  Products by Top 10 Molecule Type, H1 2014
  26Number of Products by Stage and Top 10
  Molecule Type, H1 2014 27Number of Products by
  Top 10 Therapeutic Class, H1 2014 28Number of
  Products by Stage and Top 10 Therapeutic Class,
  H1 2014 29

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.